VAV2 regulates epidermal growth factor receptor endocytosis and degradation

Oncogene

Volumn 29, Issue 17, 2010, Pages 2528-2539

  Thalappilly, S ^a,b   Soubeyran, P ^a,b   Iovanna, J L ^a,b   Dusetti, N J ^a,b  

^a INSERM   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

Author keywords

EGFR; Endosome; Receptor internalization; VAV2

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; RAB PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG; VAV 2 PROTEIN; VAV PROTEIN;

ARTICLE; CELL STRAIN HEK293; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOCYTOSIS; ENDOSOME; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; INTERNALIZATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION;

CELL LINE, TUMOR; ENDOCYTOSIS; ENDOSOMES; HUMANS; PROTO-ONCOGENE PROTEINS C-VAV; RAB5 GTP-BINDING PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 77951877243     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.1     Document Type: Article

References (57)

1. Abe K, Rossman KL, Liu B, Ritola KD, Chiang D, Campbell SL et al. (2000). Vav2 is an activator of Cdc42, Rac1, and RhoA. J Biol Chem 275: 10141-10149.
2. Aoki K, Nakamura T, Fujikawa K, Matsuda M. (2005). Local phosphatidylinositol 3,4,5-trisphosphate accumulation recruits Vav2 and Vav3 to activate Rac1/Cdc42 and initiate neurite outgrowth in nerve growth factor-stimulated PC12 cells. Mol Biol Cell 16: 2207-2217.
3. Bache KG, Stuffers S, Malerod L, Slagsvold T, Raiborg C, Lechardeur D et al. (2006). The ESCRT-III subunit hVps24 is required for degradation but not silencing of the epidermal growth factor receptor. Mol Biol Cell 17: 2513-2523.
4. Bourguignon LY, Zhu H, Zhou B, Diedrich F, Singleton PA, Hung MC. (2001). Hyaluronan promotes CD44v3-Vav2 interaction with Grb2-p185(HER2) and induces Rac1 and Ras signaling during ovarian tumor cell migration and growth. J Biol Chem 276: 48679-48692.
5. Bustelo XR. (2001). Vav proteins, adaptors and cell signaling. Oncogene 20: 6372-6381.
6. Bustelo XR. (2002). Regulation of Vav proteins by intramolecular events. Front Biosci 7: d24-d30.
7. Bustelo XR, Suen KL, Leftheris K, Meyers CA, Barbacid M. (1994). Vav cooperates with Ras to transform rodent fibroblasts but is not a Ras GDP/GTP exchange factor. Oncogene 9: 2405-2413.
8. Ceresa BP. (2006). Regulation of EGFR endocytic trafficking by rab proteins. Histol Histopathol 21: 987-993.
9. Clague MJ, Urbe S. (2006). Endocytosis: the DUB version. Trends Cell Biol 16: 551-559.
10. Cowan CW, Shao YR, Sahin M, Shamah SM, Lin MZ, Greer PL et al. (2005). Vav family GEFs link activated Ephs to endocytosis and axon guidance. Neuron 46: 205-217.
11. de Melker AA, van der Horst G, Calafat J, Jansen H, Borst J. (2001). c-Cbl ubiquitinates the EGF receptor at the plasma membrane and remains receptor associated throughout the endocytic route. J Cell Sci 114: 2167-2178.
12. Donepudi M, Resh MD. (2008). c-Src trafficking and co-localization with the EGF receptor promotes EGF ligand-independent EGF receptor activation and signaling. Cell Signal 20: 1359-1367.
13. Doody GM, Billadeau DD, Clayton E, Hutchings A, Berland R, McAdam S et al. (2000). Vav-2 controls NFAT-dependent transcription in B-but not T-lymphocytes. EMBO J 19: 6173-6184.
14. Ellis S, Mellor H. (2000). Regulation of endocytic traffic by rho family GTPases. Trends Cell Biol 10: 85-88.
15. Fernandez-Zapico ME, Gonzalez-Paz NC, Weiss E, Savoy DN, Molina JR, Fonseca R et al. (2005). Ectopic expression of VAV1 reveals an unexpected role in pancreatic cancer tumorigenesis. Cancer Cell 7: 39-49.
16. Franco M, Furstoss O, Simon V, Benistant C, Hong WJ, Roche S. (2006). The adaptor protein Tom1L1 is a negative regulator of Src mitogenic signaling induced by growth factors. Mol Cell Biol 26: 1932-1947.
17. Gavard J, Gutkind JS. (2006). VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Nat Cell Biol 8: 1223-1234.
18. Goel S, Hidalgo M, Perez-Soler R. (2007). EGFR inhibitor-mediated apoptosis in solid tumors. J Exp Ther Oncol 6: 305-320.
19. Gomez TS, Hamann MJ, McCarney S, Savoy DN, Lubking CM, Heldebrant MP et al. (2005). Dynamin 2 regulates T cell activation by controlling actin polymerization at the immunological synapse. Nat Immunol 6: 261-270.
20. Hornstein I, Alcover A, Katzav S. (2004). Vav proteins, masters of the world of cytoskeleton organization. Cell Signal 16: 1-11.
21. Houlard M, Arudchandran R, Regnier-Ricard F, Germani A, Gisselbrecht S, Blank U et al. (2002). Vav1 is a component of transcriptionally active complexes. J Exp Med 195: 1115-1127.
22. Hunker CM, Galvis A, Kruk I, Giambini H, Veisaga ML, Barbieri MA. (2006). Rab5-activating protein 6, a novel endosomal protein with a role in endocytosis. Biochem Biophys Res Commun 340: 967-975.
23. Jiang X, Sorkin A. (2002). Coordinated traffic of Grb2 and Ras during epidermal growth factor receptor endocytosis visualized in living cells. Mol Biol Cell 13: 1522-1535.
24. Kodama A, Matozaki T, Fukuhara A, Kikyo M, Ichihashi M, Takai Y. (2000). Involvement of an SHP-2-Rho small G protein pathway in hepatocyte growth factor/scatter factor-induced cell scattering. Mol Biol Cell 11: 2565-2575.
25. Liu BP, Burridge K. (2000). Vav2 activates Rac1, Cdc42, and RhoA downstream from growth factor receptors but not beta1 integrins. Mol Cell Biol 20: 7160-7169.
26. Lodhi IJ, Chiang SH, Chang L, Vollenweider D, Watson RT, Inoue M et al. (2007). Gapex-5, a Rab31 guanine nucleotide exchange factor that regulates Glut4 trafficking in adipocytes. Cell Metab 5: 59-72.
27. Marcoux N, Vuori K. (2003). EGF receptor mediates adhesion-dependent activation of the Rac GTPase: a role for phosphatidy-linositol 3-kinase and Vav2. Oncogene 22: 6100-6106.
28. Morita E, Sandrin V, Chung HY, Morham SG, Gygi SP, Rodesch CK et al. (2007). Human ESCRT and ALIX proteins interact with proteins of the midbody and function in cytokinesis. EMBO J 26: 4215-4227.
29. Mosesson Y, Mills GB, Yarden Y. (2008). Derailed endocytosis: an emerging feature of cancer. Nat Rev Cancer 8: 835-850.
30. Narumiya S, Yasuda S. (2006). Rho GTPases in animal cell mitosis. Curr Opin Cell Biol 18: 199-205.
31. Orth JD, Krueger EW, Weller SG, McNiven MA. (2006). A novel endocytic mechanism of epidermal growth factor receptor sequestration and internalization. Cancer Res 66: 3603-3610.
32. Pandey A, Podtelejnikov AV, Blagoev B, Bustelo XR, Mann M, Lodish HF. (2000). Analysis of receptor signaling pathways by mass spectrometry: identification of vav-2 as a substrate of the epidermal and platelet-derived growth factor receptors. Proc Natl Acad Sci USA 97: 179-184. (Pubitemid 30055804)
33. Patel V, Rosenfeldt HM, Lyons R, Servitja JM, Bustelo XR, Siroff M et al. (2007). Persistent activation of Rac1 in squamous carcinomas of the head and neck: evidence for an EGFR/Vav2 signaling axis involved in cell invasion. Carcinogenesis 28: 1145-1152.
34. Peng F, Zhang B, Ingram AJ, Gao B, Zhang Y, Krepinsky JC. (2010). Mechanical stretch-induced RhoA activation is mediated by the RhoGEF Vav2 in mesangial cells. Cell Signal 22: 34-40.
35. Puertollano R. (2005). Interactions of TOM1L1 with the multi-vesicular body sorting machinery. J Biol Chem 280: 9258-9264.
36. Romero F, Fischer S. (1996). Structure and function of vav. Cell Signal 8: 545-553.
37. Schuebel KE, Bustelo XR, Nielsen DA, Song BJ, Barbacid M, Goldman D et al. (1996). Isolation and characterization of murine vav2, a member of the vav family of proto-oncogenes. Oncogene 13: 363-371.
38. Servitja JM, Marinissen MJ, Sodhi A, Bustelo XR, Gutkind JS. (2003). Rac1 function is required for Src-induced transformation. Evidence of a role for Tiam1 and Vav2 in Rac activation by Src. J Biol Chem 278: 34339-34346.
39. Seye CI, Yu N, Gonzalez FA, Erb L, Weisman GA. (2004). The P2Y2 nucleotide receptor mediates vascular cell adhesion molecule-1 expression through interaction with VEGF receptor-2 (KDR/Flk-1). J Biol Chem 279: 35679-35686.
40. Sorkin A, Goh LK. (2008). Endocytosis and intracellular trafficking of ErbBs. Exp Cell Res 314: 3093-3106.
41. Soubeyran P, Kowanetz K, Szymkiewicz I, Langdon WY, Dikic I. (2002). Cbl-CIN85-endophilin complex mediates ligand-induced downregulation of EGF receptors. Nature 416: 183-187.
42. Stuffers S, Brech A, Stenmark H. (2009). ESCRT proteins in physiology and disease. Exp Cell Res 315: 1619-1626.
43. Su X, Kong C, Stahl PD. (2007). GAPex-5 mediates ubiquitination, trafficking, and degradation of epidermal growth factor receptor. J Biol Chem 282: 21278-21284.
44. Swat W, Fujikawa K. (2005). The Vav family: at the crossroads of signaling pathways. Immunol Res 32: 259-265.
45. Tamas P, Solti Z, Bauer P, Illes A, Sipeki S, Bauer A et al. (2003). Mechanism of epidermal growth factor regulation of Vav2, a guanine nucleotide exchange factor for Rac. J Biol Chem 278: 5163-5171.
46. Tamas P, Solti Z, Buday L. (2001). Membrane-targeting is critical for the phosphorylation of Vav2 by activated EGF receptor. Cell Signal 13: 475-481.
47. Thalappilly S, Suliman M, Gayet O, Soubeyran P, Hermant A, Lecine P et al. (2008). Identification of multi-SH3 domain-containing protein interactome in pancreatic cancer: a yeast two-hybrid approach. Proteomics 8: 3071-3081.
48. Tu S, Wu WJ, Wang J, Cerione RA. (2003). Epidermal growth factor-dependent regulation of Cdc42 is mediated by the Src tyrosine kinase. J Biol Chem 278: 49293-49300.
49. Umebayashi K, Stenmark H, Yoshimori T. (2008). Ubc4/5 and c-Cbl continue to ubiquitinate EGF receptor after internalization to facilitate polyubiquitination and degradation. Mol Biol Cell 19: 3454-3462.
50. Ung CY, Li H, Ma XH, Jia J, Li BW, Low BC et al. (2008). Simulation of the regulation of EGFR endocytosis and EGFR-ERK signaling by endophilin-mediated RhoA-EGFR crosstalk. FEBS Lett 582: 2283-2290.
51. Wadsworth P. (2005). Cytokinesis: Rho marks the spot. Curr Biol 15: R871-R874.
52. Wang Y, Pennock S, Chen X, Wang Z. (2002). Endosomal signaling of epidermal growth factor receptor stimulates signal transduction pathways leading to cell survival. Mol Cell Biol 22: 7279-7290.
53. Williams RL, Urbe S. (2007). The emerging shape of the ESCRT machinery. Nat Rev Mol Cell Biol 8: 355-368.
54. Wu WJ, Tu S, Cerione RA. (2003). Activated Cdc42 sequesters c-Cbl and prevents EGF receptor degradation. Cell 114: 715-725.
55. Yamazaki T, Zaal K, Hailey D, Presley J, Lippincott-Schwartz J, Samelson LE. (2002). Role of Grb2 in EGF-stimulated EGFR internalization. J Cell Sci 115: 1791-1802.
56. Yanagida-Ishizaki Y, Takei T, Ishizaki R, Imakagura H, Takahashi S, Shin HW et al. (2008). Recruitment of Tom1L1/Srcasm to endosomes and the midbody by Tsg101. Cell Struct Funct 33: 91-100.
57. Zeng L, Sachdev P, Yan L, Chan JL, Trenkle T, McClelland M et al. (2000). Vav3 mediates receptor protein tyrosine kinase signaling, regulates GTPase activity, modulates cell morphology, and induces cell transformation. Mol Cell Biol 20: 9212-9224.